241 related articles for article (PubMed ID: 35902966)
1. Recurrent squamous cell carcinoma and a novel mutation in a patient with xeroderma pigmentosum: a case report.
Şahin EA; Taşkıran EZ; Kiper PÖŞ; Aydın B; Utine E
J Med Case Rep; 2022 Jul; 16(1):306. PubMed ID: 35902966
[TBL] [Abstract][Full Text] [Related]
2. A novel missense variant and multiexon deletion causing a delayed presentation of xeroderma pigmentosum, group C.
Macke EL; Morales-Rosado JA; Gupta A; Schmitz CT; Kruisselbrink T; Lanpher B; Klee EW
Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32843428
[TBL] [Abstract][Full Text] [Related]
3. Lung adenocarcinoma concomitant with xeroderma pigmentosum: a case report.
Matsumoto M; Kaneshiro K; Takatsuki K
J Med Case Rep; 2021 Mar; 15(1):160. PubMed ID: 33781316
[TBL] [Abstract][Full Text] [Related]
4. A novel XPA splice-site mutation identified in a 4-year-old Filipino girl with xeroderma pigmentosum.
Reyes HH; Lin YC; Hsu CK; Guevara BEK
Australas J Dermatol; 2023 May; 64(2):e165-e167. PubMed ID: 36866916
[TBL] [Abstract][Full Text] [Related]
5. A case of lip squamous cell carcinoma with a familial history of Xeroderma pigmentosum.
Dartaha R; Benmelouka AY; Jobran AWM
Oral Oncol; 2020 Dec; 111():104896. PubMed ID: 32654871
[TBL] [Abstract][Full Text] [Related]
6. Severe cisplatin-induced renal toxicity in a patient with xeroderma pigmentosum.
Gilbar PJ; Pokharel K
J Oncol Pharm Pract; 2022 Mar; 28(2):466-470. PubMed ID: 34647821
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel protein truncating mutation p.Asp98* in XPC associated with xeroderma pigmentosum in a consanguineous Pakistani family.
Ali MZ; Blatterer J; Khan MA; Schaflinger E; Petek E; Ahmad S; Khan E; Windpassinger C
Mol Genet Genomic Med; 2020 Feb; 8(2):e1060. PubMed ID: 31923348
[TBL] [Abstract][Full Text] [Related]
8. Xeroderma pigmentosum: a case report and review of the literature.
Feller L; Wood NH; Motswaledi MH; Khammissa RA; Meyer M; Lemmer J
J Prev Med Hyg; 2010 Jun; 51(2):87-91. PubMed ID: 21155411
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of non-melanoma skin cancer in three patients with Xeroderma Pigmentosum by modified ALA-PDT.
Zheng J; Liu W; Zhou Z; Cao Z; Zhao Z; Wang X; Li M; Zhang G
Photodiagnosis Photodyn Ther; 2023 Sep; 43():103694. PubMed ID: 37422200
[TBL] [Abstract][Full Text] [Related]
10. Multiple cutaneous malignancies in a patient of xeroderma pigmentosum.
Grampurohit VU; Dinesh US; Rao R
J Cancer Res Ther; 2011; 7(2):205-7. PubMed ID: 21768716
[TBL] [Abstract][Full Text] [Related]
11. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
[TBL] [Abstract][Full Text] [Related]
12. Clinical, cellular, and molecular features of an Israeli xeroderma pigmentosum family with a frameshift mutation in the XPC gene: sun protection prolongs life.
Slor H; Batko S; Khan SG; Sobe T; Emmert S; Khadavi A; Frumkin A; Busch DB; Albert RB; Kraemer KH
J Invest Dermatol; 2000 Dec; 115(6):974-80. PubMed ID: 11121128
[TBL] [Abstract][Full Text] [Related]
13. Xeroderma pigmentosum variant: squamous cell carcinoma of the lower lip harboring exon 11 mutation of POLH.
Pereira TDSF; Castro LP; Menck CFM; Maia MHT; Souza LL; Fonseca FP; Pontes HAR; Pontes FSC; Gomez RS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Sep; 132(3):e97-e105. PubMed ID: 34030998
[TBL] [Abstract][Full Text] [Related]
14. [Multiple facial squamous cell carcinomas in a child, revealing a xeroderma pigmentosum].
Beogo R; Andonaba JB; Bouletreau P; Traore Sawadogo H; Traore A
Rev Stomatol Chir Maxillofac; 2012 Feb; 113(1):50-2. PubMed ID: 22056175
[TBL] [Abstract][Full Text] [Related]
15. Germline and somatic mutations of the INK4a-ARF gene in a xeroderma pigmentosum group C patient.
Soufir N; Ribojad M; Magnaldo T; Thibaudeau O; Delestaing G; Daya-Grosjean L; Rivet J; Sarasin A; Basset-Seguin N
J Invest Dermatol; 2002 Dec; 119(6):1355-60. PubMed ID: 12485439
[TBL] [Abstract][Full Text] [Related]
16. Xeroderma pigmentosum: neck lymph node metastasis of a squamous cell carcinoma of the skin treated with cetuximab.
Rubió Casadevall J; Graña-Suárez B; Hernandez-Yagüe X; Vayreda Ribera J; Huc Grasa O; Brunet Vidal J
Eur J Dermatol; 2009; 19(2):163-5. PubMed ID: 19106040
[TBL] [Abstract][Full Text] [Related]
17. Radiation therapy for squamous cell cancer of the skin in a patient with xeroderma pigmentosum.
Altinok P; Tekçe E; Ergün SS; Mayadagli A
J Cancer Res Ther; 2022; 18(3):801-803. PubMed ID: 35900561
[TBL] [Abstract][Full Text] [Related]
18. [Xeroderma pigmentosum].
Stary A; Sarasin A
Presse Med; 1997 Dec; 26(40):1992-7. PubMed ID: 9537004
[TBL] [Abstract][Full Text] [Related]
19. A stop codon in xeroderma pigmentosum group C families in Turkey and Italy: molecular genetic evidence for a common ancestor.
Gozukara EM; Khan SG; Metin A; Emmert S; Busch DB; Shahlavi T; Coleman DM; Miller M; Chinsomboon N; Stefanini M; Kraemer KH
J Invest Dermatol; 2001 Aug; 117(2):197-204. PubMed ID: 11511294
[TBL] [Abstract][Full Text] [Related]
20. Re-irradiation of metastatic disease in the neck from xeroderma pigmentosum.
Wei CC; Sanfilippo NJ; Myssiorek D
Curr Oncol; 2010 Jun; 17(3):83-5. PubMed ID: 20567629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
